Erythroxa is the trade name, and the generic name of the drug is Gefitinib Tablets, which works by inhibiting the epidermal growth factor receptor, and acts as a treatment for non-small cell lung cancer.
Gefitinib Tablets is a kind of antitumor drugs, through the inhibition of wild-type and certain mutant epidermal growth factor receptor to play a role, clinically used in the treatment of locally advanced or metastatic non-small cell lung cancer with sensitive mutations in the epidermal growth factor receptor tyrosine kinase gene.
It should be noted that the use of gefitinib tablets is prohibited for those who are allergic to any component of this drug or have a history of severe allergic reactions, and its use is not recommended for children, and some patients may experience adverse reactions such as diarrhea, nausea, vomiting, stomatitis, rash, acne, itching, fever, weakness, etc., and should consult a doctor if the discomfort is more serious.
Patients should use Gefitinib tablets as prescribed by the doctor, and should not use the drug blindly on their own, so as not to affect the condition, or side effects.